Special Issue "Diagnostic Challenge and Therapeutic Approaches in Human Sepsis Based on the Appearance of Endotoxemia and Beta-D-Glucanemia"
Deadline for manuscript submissions: closed (31 March 2021) | Viewed by 18598
2. Department of Host Defense and Biochemical Research, Juntendo University Graduate School of Medicine, Tokyo 113-8431, Japan
3. Tokyo University of Pharmacy and Life Science, Tokyo 192-0392, Japan
Interests: endotoxin(LPS), (1→3)-beta-D-glucan, LAL assay; sepsis; TLR4; host defense peptides; anti-endotoxin therapy
Interests: innate immunity; (1→3)-beta-D-glucan; mycosis; allergy; C-type lectin receptor; Dectin-1; beta-glucan binding protein
We are pleased to introduce to you this Special Issue of Molecular Toxicology Section of the International Journal of Molecular Sciences, on "Diagnostic Challenge and Therapeutic Approaches in Human Sepsis Based on the Appearance of Endotoxemia and Beta-D-Glucanemia".
Endotoxins, also called lipopolysaccharides (LPS), are the major constituent of the outer membrane of Gram-negative bacteria and possess a wide variety of biological effects and pathogenicity in human, such as pyrogenesity, lethality, inflammatory cytokine response via TLR4 signaling, or excessive activation of the coagulation system, leading to disseminated intravascular coagulation (DIC). Cytokine and chemokine production by a broad range of immune cells result in a substantial part of the pathophysiology of endotoxin shock, suggesting a relationship with a number of endogenous risk factors, including enhanced intestinal epithelial permeability and bacterial translocation along with underlying conditions. In addition, invasive fungal infections are an increasingly frequent cause of sepsis. Thus, fungal (1→3)-beta-D-glucan, a major component of the cell wall as well as endotoxin, have attracted a considerable amount of interest in applications as potential prognostic, diagnostic, and therapeutic markers in blood or body fluids.
In this Special Issue, we will focus on cellular and molecular mechanisms of endotoxin/beta-D-glucan activities; recent advances, limitations, and further challenges to the early detection of endotoxemia/beta-D-glucanemia, primarily with the Limulus amebocyte lysate assay (conventional/recombinant); and promising therapeutic approaches based on cytokine/chemokine blockades, anti-endotoxin agents, host defense (antimicrobial) peptides, antifungal agents, highly effective anticoagulants, or direct hemoperfusion, with the aim to pave the way to successful innovative treatments and management of sepsis or septic shock.Dr. Hiroshi Tamura
Dr. Yoshiyuki Adachi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Endotoxin (LPS)
- Limulus amebocyte lysate (LAL)
- host defense peptides
- anti-endotoxin therapy